The invention provides an immunogenic composition comprising: a) a conjugate that is a capsular saccharide from GBS serotype Ia conjugated to a carrier protein; b) a conjugate that is a capsular saccharide from GBS serotype Ib conjugated to a carrier protein; c) a conjugate that is a capsular saccharide from GBS serotype III conjugated to a carrier protein; d) a conjugate that is a capsular saccharide from GBS serotype II conjugated to a carrier protein; and e) a conjugate that is a capsular saccharide from GBS serotype V conjugated to a carrier protein.
申请公布号
CA2883481(A1)
申请公布日期
2014.04.10
申请号
CA20132883481
申请日期
2013.10.03
申请人
NOVARTIS AG
发明人
GRANDI, GUIDO;MARGARIT Y ROS, IMMACULADA;MAIONE, DOMENICO